Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.645    0.00 (0.00%)
Bid:
2.45
Ask:
14.00
Spread: 11.55 (471.429%)
Market Cap: £4.83m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Achieves US$1m Milestone

31 Jan 2012 07:00

RNS Number : 4292W
Nanoco Group PLC
31 January 2012
Β 

ο»Ώ

For immediate release

31 January 2012

Β 

Β 

NANOCO GROUP PLC

("Nanoco" or "the Company")

Β 

Achieves US$1m Performance Milestone for Green Quantum Dots

Β 

Β 

Nanoco Group plc(AIM: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, announces that it has achieved the performance milestone for green quantum dots being developed in its supply and licence agreement with a major Japanese corporation, triggering a US$1 million payment.

Β 

The criteria for achieving the milestone included a performance life of at least 50,000 hours.

Β 

Nanoco will now begin production of a 1kg batch of the green quantum dots. Once produced, and validated by the customer, the 1kg batch will attract a US$2 million milestone payment.

Β 

The performance milestone for the green quantum dots follows the successful production last year of a 1kg batch of red quantum dots for the same customer.

Β 

The customer's intention is to combine the red and green quantum dots with blue LEDs to produce a highly efficient source of white light for multiple potential applications including backlighting for LCD displays and LED-based general lighting.

Β 

Β 

Michael Edelman, Nanoco's Chief Executive Officer, said: "We are delighted to have demonstrated that the performance of these green quantum dots meets our customer's specification as it marks an important step towards the customer's launch of a marketed product.

Β 

"Last year, we successfully produced 1kg of red quantum dots for the same customer and we will now begin production of a 1kg batch of green dots. The customer will then be able to combine the red and green dots with blue LEDs to produce a highly efficient source of white light for multiple end-uses."

Β 

Β 

Β 

Β 

Β 

For further information please contact:

Β 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

Colin White, Chief Financial Officer

Bank of America Merrill Lynch - Joint Broker

Tel: +44 (0) 20 7996 2490

Will Smith

Canaccord Genuity - Nomad and Joint Broker

Tel: +44 (0) 20 7050 6500

Simon Bridges

Cameron Duncan

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Jessica Fontaine

Β 

Β 

Β 

Β 

Β 

Notes for editors:

Β 

AboutΒ Nanoco GroupΒ plc

Nanoco is a world leader in the development and manufacture of commercial quantities of quantum dots for use in multiple applications includingΒ lighting, solar cells and biological imaging.Β Nanoco's quantum dots, which are free of heavy metals and comply with RoHS legislation, can be combined into a wide range of materials including liquids, polymers and glass.Β Nanoco forms strategic partnerships with major end users across a range of applications.

Nanoco was founded in 2001 and is based inΒ Manchester, UK. Nanoco began trading on the AIM market of the London Stock Exchange in May 2009 under the ticker symbol NANO.

For further information, please visitΒ www.nanocogroupplc.com.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCBMMRTMBIJBJT
Date   Source Headline
9th Jun 20267:00 amRNSGlass Lewis recommendation
5th Jun 202611:55 amRNSTR-1: Notification of major holdings
27th May 20267:00 amRNSIntention to delist from London Stock Exchange
20th Apr 20265:37 pmRNSDirector/PDMR Shareholding
20th Apr 20267:00 amRNSInterim Results
13th Apr 20267:00 amRNSNotice of Results
26th Mar 20267:00 amRNSShoei Litigation Conclusion
19th Mar 20267:00 amRNSStay of Shoei Litigation
23rd Feb 20267:00 amRNSShoei Litigation Update
26th Jan 20267:00 amRNSConclusion of CDX process & Directorate changes
15th Jan 20261:08 pmRNSReceipt of Litigation Proceeds
13th Jan 20264:50 pmRNSResult of AGM
12th Jan 20267:00 amRNSLitigation update
9th Dec 20257:00 amRNSBlocklisting Six-Monthly Return
8th Dec 202511:16 amRNSNotice of AGM
27th Nov 20257:00 amRNSResponse to non-infringement claim
26th Nov 20257:00 amRNSAnnual Report and Accounts
20th Nov 20257:00 amRNSLitigation outcome – Settlement agreed
18th Nov 20257:07 amRNSPreliminary Results
13th Nov 20257:00 amRNSNotice of Results
4th Nov 20257:06 amRNSExtension of Joint Development Agreement
15th Oct 20257:00 amRNS-RAwarding of Government Grant
30th Sep 20254:30 pmRNSTotal Voting Rights and Share Capital
8th Sep 20257:00 amRNSIssue of Equity and Director/PDMR Shareholdings
19th Aug 20257:00 amRNSFull Year Trading Update & Director Retirement
9th Jun 20257:00 amRNSBLOCKLISTING SIX-MONTHLY RETURN
28th Apr 202510:48 amRNSJoint Development Agreement
25th Apr 20257:00 amRNSPatent infringement lawsuit against LG
17th Apr 20253:54 pmRNSHigh Court Confirmation of Capital Reduction
15th Apr 20257:00 amRNSInterim Results & Investor Presentation
13th Mar 20257:00 amRNSNotice of Results
21st Jan 20252:20 pmRNSAnnual General Meeting – Voting Results
18th Dec 20248:26 amRNSDirector/PDMR Shareholding
13th Dec 20241:23 pmRNSResult of General Meeting
9th Dec 20247:00 amRNSBlock Listing Six Monthly Return
6th Dec 20246:30 pmRNSNotice of AGM
29th Nov 20247:00 amRNSGlass Lewis and ISS recommendations
28th Nov 20243:23 pmRNSDirector/PDMR Shareholding
28th Nov 20241:25 pmRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNS2024 Annual Report
20th Nov 20247:00 amRNSPreliminary Results
15th Nov 202411:00 amRNSPosting of Circular and Notice of General Meeting
30th Oct 20247:01 amRNSCompletion of Buyback Programme
30th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Oct 20247:00 amRNSReceipt of General Meeting Requisition Notice
23rd Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Oct 20247:00 amRNSAppointment of CEO and Notice of Results
22nd Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.